Cancer Pharmacology & Therapeutics
This session focuses
on the pharmacological basis of cancer therapy,
including mechanisms of drug action, pharmacokinetics, and toxicity profiles.
Experts will discuss drug resistance, combination regimens, and
pharmacogenomics in oncology. Emerging agents
like antibody-drug conjugates (ADCs) and targeted kinase inhibitors will be
featured. Case discussions will highlight the optimisation of dosing and
therapeutic drug monitoring to improve clinical outcomes.
Subtracks:
- Mechanisms of Action of Cancer Therapeutics
- Pharmacogenomics in Oncology Drug Selection
- Drug-Drug Interactions and Toxicity Management
- Antibody-Drug Conjugates and Biologic Therapies
- Therapeutic Drug Monitoring in Oncology